Farallon Capital Management LLC Sarepta Therapeutics, Inc. Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Farallon Capital Management LLC holds 2,580,000 shares of SRPT stock, worth $307 Million. This represents 1.62% of its overall portfolio holdings.

Number of Shares

2,580,000

Previous 133,300 1835.48%

Holding current value

$307 Million

Previous $21.1 Million 1430.04%

% of portfolio

1.62%

Previous 0.1%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $35.4 Million - $44.7 Million	285,000 Added 12.42%	2,580,000 $322 Million
Q2 2024 Aug 14, 2024	SELL	$113.33 - $163.85 $18 Million - $26 Million	-158,500 Reduced 6.46%	2,295,000 $363 Million
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $117 Million - $176 Million	1,243,427 Added 102.76%	2,453,500 $318 Million
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $81.5 Million - $151 Million	1,210,073 New	1,210,073 $117 Million
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $141 Million - $170 Million	1,375,200 New	1,375,200 $167 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $31.1 Million - $45.9 Million	291,900 Added 31.96%	1,205,200 $138 Million
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $1.83 Million - $2.43 Million	-15,600 Reduced 1.68%	913,300 $126 Million
Q4 2022 Feb 14, 2023	BUY	$100.86 - $132.13 $17.5 Million - $23 Million	173,950 Added 23.04%	928,900 $120 Million
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $32.6 Million - $51.3 Million	-430,101 Reduced 36.29%	754,950 $83.5 Million
Q2 2022 Aug 15, 2022	BUY	$62.69 - $88.44 $12.1 Million - $17.1 Million	193,076 Added 19.46%	1,185,051 $88.8 Million
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $9.66 Million - $13.8 Million	152,966 Added 18.23%	991,975 $77.5 Million
Q4 2021 Feb 14, 2022	BUY	$77.28 - $99.42 $52.3 Million - $67.3 Million	677,009 Added 417.91%	839,009 $75.6 Million
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $9.1 Million - $12.8 Million	-138,000 Reduced 46.0%	162,000 $15 Million
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $21.7 Million - $50.7 Million	-300,000 Reduced 50.0%	300,000 $22.4 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $9.53 Million - $12.9 Million	75,000 Added 14.29%	600,000 $84.3 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $16.3 Million - $30 Million	175,000 Added 50.0%	525,000 $84.2 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $12.4 Million - $19.7 Million	-150,000 Reduced 30.0%	350,000 $34.2 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $16.8 Million - $22.8 Million	-150,000 Reduced 23.08%	500,000 $76 Million
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $1.07 Million - $1.52 Million	10,000 Added 1.56%	650,000 $77.5 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $43.3 Million - $66.2 Million	445,000 Added 228.21%	640,000 $69.8 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $22.5 Million - $31.5 Million	195,000 New	195,000 $31.5 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Sarepta Therapeutics, Inc. Transaction History